Logo image of DHCNI

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

NASDAQ:DHCNI - Nasdaq - US25525P2065 - Currency: USD

16.8  -0.02 (-0.12%)

Fundamental Rating

2

Taking everything into account, DHCNI scores 2 out of 10 in our fundamental rating. DHCNI was compared to 130 industry peers in the Diversified REITs industry. DHCNI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DHCNI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHCNI had negative earnings in the past year.
DHCNI had a positive operating cash flow in the past year.
In the past 5 years DHCNI reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

DHCNI has a worse Return On Assets (-5.86%) than 86.15% of its industry peers.
DHCNI has a worse Return On Equity (-15.04%) than 81.54% of its industry peers.
Industry RankSector Rank
ROA -5.86%
ROE -15.04%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With a Gross Margin value of 17.75%, DHCNI is not doing good in the industry: 93.85% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DHCNI has declined.
The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DHCNI has more shares outstanding
The number of shares outstanding for DHCNI has been increased compared to 5 years ago.
The debt/assets ratio for DHCNI is higher compared to a year ago.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.39, we must say that DHCNI is in the distress zone and has some risk of bankruptcy.
DHCNI's Altman-Z score of 0.39 is in line compared to the rest of the industry. DHCNI outperforms 41.54% of its industry peers.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNI has dependencies on debt financing.
With a Debt to Equity ratio value of 1.44, DHCNI perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACC6.7%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNI has a Current Ratio of 7.40. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
DHCNI's Current ratio of 7.40 is amongst the best of the industry. DHCNI outperforms 96.15% of its industry peers.
DHCNI has a Quick Ratio of 7.40. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
DHCNI has a Quick ratio of 7.40. This is amongst the best in the industry. DHCNI outperforms 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 7.4
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.62% over the past year.
Looking at the last year, DHCNI shows a small growth in Revenue. The Revenue has grown by 5.33% in the last year.
DHCNI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)39.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.89%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.34%

3.2 Future

DHCNI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.22% yearly.
The Revenue is expected to grow by 4.05% on average over the next years.
EPS Next Y37.96%
EPS Next 2Y16.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.6%
Revenue Next 2Y4.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

93.85% of the companies in the same industry are cheaper than DHCNI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.28
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as DHCNI's earnings are expected to grow with 16.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.22%
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

DHCNI has a Yearly Dividend Yield of 1.13%.
With a Dividend Yield of 1.13, DHCNI pays less dividend than the industry average, which is at 6.52. 91.54% of the companies listed in the same industry pay a better dividend than DHCNI!
Compared to an average S&P500 Dividend Yield of 2.35, DHCNI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of DHCNI decreases each year by -45.60%.
DHCNI has been paying a dividend for over 5 years, so it has already some track record.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.29%
EPS Next 2Y16.22%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (8/1/2025, 8:00:00 PM)

16.8

-0.02 (-0.12%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners77.49%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap4.05B
Analysts48
Price Target16.1 (-4.17%)
Short Float %0%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-3.29%
Div Incr Years0
Div Non Decr Years3
Ex-Date07-15 2025-07-15 (0.3515625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)49.8%
Min EPS beat(2)-22.91%
Max EPS beat(2)122.5%
EPS beat(4)2
Avg EPS beat(4)45.86%
Min EPS beat(4)-23.76%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)21.36%
EPS beat(12)4
Avg EPS beat(12)5.31%
EPS beat(16)5
Avg EPS beat(16)-4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.64%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)1.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.58%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.37%
PT rev (1m)-3.05%
PT rev (3m)-18.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10%
EPS NY rev (1m)0%
EPS NY rev (3m)17.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.68
P/FCF N/A
P/OCF 50.42
P/B 2.08
P/tB 2.08
EV/EBITDA 27.28
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.33
OCFY1.98%
SpS6.27
BVpS8.07
TBVpS8.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.86%
ROE -15.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.75%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 11.65
Cap/Depr 68.74%
Cap/Sales 12.88%
Interest Coverage N/A
Cash Conversion 33.45%
Profit Quality N/A
Current Ratio 7.4
Quick Ratio 7.4
Altman-Z 0.39
F-Score7
WACC6.7%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.89%
EPS Next Y37.96%
EPS Next 2Y16.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.33%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.34%
Revenue Next Year3.6%
Revenue Next 2Y4.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year369.96%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y71.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y397.18%
OCF growth 3YN/A
OCF growth 5Y-15.84%